US28658R1068
US28658R1068
Climb Bio, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 631.8M EUR | 748.97M EUR | 327.21M EUR | 191.07M EUR |
Enterprise Value | 441.95M EUR | 706.18M EUR | 319.34M EUR | 155.92M EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -10.97x | -- | -- | -- |
Price to Sales | -- | -- | -- | -- |
Price to Book | 2.64x | 3.13x | 2.21x | 1.19x |
EV/Revenue | -- | -- | -- | -- |
EV/EBITDA | -6.84x | -- | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -5.38% | -7.09% | -16.35% | -20.47% |